|

A novel hGIIA-Vimentin Inhibitor Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Filamon LTD1

Indications

  • Prostate Cancers1
  • Glioblastoma Multiforme (GBM)1
  • Skin Cancer1
  • Lung Cancers1
  • Pancreas Cancer1

Other1 trial

Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.